Infinity Pharmaceuticals Buy or Sell Recommendation

Macroaxis provides Infinity Pharmaceuticals Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Infinity Pharmaceuticals positions. The advice algorithm takes into account all of Infinity Pharmaceuticals Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Infinity Pharmaceuticals buy-and-hold prospective. Please also check Infinity Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Infinity Pharmaceuticals Inc -- USA Stock  

USD 1.85  0.04  2.21%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Infinity Pharmaceuticals Inc is 'Strong Sell'.
For the selected time horizon Infinity Pharmaceuticals Inc has a mean deviation of 1.73, semi deviation of 0.0, standard deviation of 2.6, variance of 6.75, downside variance of 0.0 and semi variance of 0.0
We provide buy, hold, or sell suggestion to complement the regular expert consensus on Infinity Pharmaceuticals. Our dynamic recommendation engine utilizes multi - dimensional algorithm to analyze the organization potential to grow using all technical and fundamental data available at the time. To make sure Infinity Pharmaceuticals Inc is not overpriced, please check out all Infinity Pharmaceuticals fundamentals including its Shares Owned by Institutions, Net Income, Short Ratio, as well as the relationship between Price to Sales and Debt to Equity . Please also validate Infinity Pharmaceuticals Price to Earning to confirm your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Returns Distribution Density

Mean Return0.54Value At Risk5.29
Potential Upside2.39Standard Deviation2.60
 Return Density 
      Distribution 

Infinity Pharmaceuticals Greeks

α
Alpha over DOW
=0.65
β
Beta against DOW=0.46
σ
Overall volatility
=2.66
Ir
Information ratio =0.13

Infinity Pharmaceuticals Volatility Alert

Infinity Pharmaceuticals Inc exhibits very low volatility with skewness of -1.01 and kurtosis of 1.73. However, we advise investors to further study Infinity Pharmaceuticals Inc technical indicators to make sure all market info is available and is reliable.
    
 Better Than Average     
    
 Worse Than Average Compare Infinity Pharmaceuticals to competition
FundamentalsInfinity PharmaceuticalsPeer Average
Return On Equity(73.91) % (15.17) %
Return On Asset(27.38) % (15.64) %
Operating Margin(789.30) % (10.91) %
Current Valuation44.75 M152.14 B
Shares Outstanding50.71 M1.43 B
Shares Owned by Insiders2.68 % 6.91 %
Shares Owned by Institutions54.67 % 18.37 %
Number of Shares Shorted1.98 M3.24 M
Price to Earning1.63 times40.69 times
Price to Book1.76 times14.44 times
Price to Sales15.64 times17.81 times
Revenue6 M9.85 B
Gross Profit18.72 M21.75 B
EBITDA(44.86 M)1.41 B
Net Income(57.46 M)517.71 M
Cash and Equivalents55.58 M3.89 B
Cash per Share1.10 times5.17 times
Total Debt6 M7.36 B
Debt to Equity11.20 % 0.72 %
Current Ratio5.88 times3.30 times
Book Value Per Share1.05 times13.64 times
Cash Flow from Operations(58.89 M)1.25 B
Short Ratio1.06 times2.09 times
Earnings Per Share1.14 times2.30 times
Price to Earnings To Growth0.02 times1.22 times
Number of Employees5610.67 K
Beta2.660.34
Market Capitalization93.82 M29.78 B
Total Asset288.82 M126.86 B
Retained Earnings(595.59 M)38.24 B
Working Capital184.64 M3.58 B
Current Asset254.7 M36.8 B
Current Liabilities70.06 M33.34 B
SellBuy
Strong Sell

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
   Infinity Pharmaceuticals exotic insider transaction detected [view details]
Risk Adjusted Performance0.37
Market Risk Adjusted Performance1.21
Mean Deviation1.73
Coefficient Of Variation479.93
Standard Deviation2.6
Variance6.75
Information Ratio0.13
Jensen Alpha0.65
Total Risk Alpha0.23
Treynor Ratio1.2
Maximum Drawdown10.01
Value At Risk5.29
Potential Upside2.39
Skewness1.01
Kurtosis1.73

Current Valuation

Infinity Pharmaceuticals Current Valuation Analysis
Infinity Pharmaceuticals Inc is rated second overall in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceutical Products industry is currently estimated at about 651.72 Million. Infinity Pharmaceuticals holds roughly 44.75 Million in current valuation claiming about 7% of equities listed under Pharmaceutical Products industry.